Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Valneva announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ®
    8 August 2025

    Valneva announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ®

    Valneva SE announced that the FDA has removed its recommended pause in the use of IXCHIQ in individuals 60 years of age and older and has approved updates to the Prescribing Information for IXCHIQ.
  • 8 August 2025
    Cormedix to acquire Melinta Therapeutics
    CorMedix Inc. a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC, a private commercial-stage company providing innovative therapies for acute and life-threatening illnesses announced a definitive agreement for CorMedix to acquire Melinta.
  • 5 August 2025
    LENZ Therapeutics announces USFDA approval of VIZZ for the Treatment of Presbyopia

    LENZ Therapeutics, Inc announced the US Food and Drug Administration approved VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults. Samples are anticipated in the United States as early as October 2025, with commercial product to be broadly available by mid-Q4 2025. Direct-to-eye care professional sales and marketing activities to be initiated immediately.

  • 5 August 2025
    AbbVie's RINVOQ® Shows Promising Results in Phase 3 Trial for Severe Alopecia Areata
    AbbVie announced positive topline results from the first of two pivotal studies of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of upadacitinib (RINVOQ®; 15 mg and 30 mg, once daily) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline SALT score of 83.8 (approximately 16% scalp hair coverage).
  • 1 August 2025
    Trump Sends Ultimatum to Big Pharma : Slash Drug Prices or Face Action
    US President Donald J. Trump has issued a sweeping ultimatum to 17 of the worlds largest pharmaceutical companies, demanding they drastically lower drug prices for Americans within 60 days or face aggressive regulatory and trade action.
  • 1 August 2025
    Government intensifies promotion and regulation of AYUSH systems of medicine across India
    The Ministry of Ayush is actively promoting and strengthening the AYUSH systems of medicine Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homoeopathy through a comprehensive strategy supported by both centrally sponsored and central sector schemes.
  • 1 August 2025
    A new approach to treatment of liver cirrhosis
    A team of Indian scientists may have found a way to improve the drainage capacity of lymphatic vessels in the liver and intestine that fails in case of cirrhosis, by using nanocarriers filled with a powerful protein called VEGF-C.
  • 30 July 2025
    FDA Approves Medication to Treat 2 Rare Diseases that Can Lead to Kidney Failure

    The U.S. Food and Drug Administration (FDA) approved a new indication for Empaveli (pegcetacoplan) injection to treat adults and children aged 12 years and older with C3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN), two rare kidney diseases that can cause kidney failure. This will be the first medication approved for children with C3G and the first medication approved for the treatment of adults and children with primary IC-MPGN.  

  • 25 July 2025
    New Hope for HIV Cure: Scientists Discover Special Killer T Cells That Hunt Hidden Viruses
    New research has taken us a step closer to finding a cure for human immunodeficiency virus, as well as other infections including the glandular fever virus, which is associated with the development of lymphoma.
  • 25 July 2025
    Swiss Genome of the 1918 Influenza Virus Reconstructed
    Researchers from the universities of Basel and Zurich have used a historical specimen from UZHs Medical Collection to decode the genome of the virus responsible for the 1918–1920 influenza pandemic in Switzerland.
Subscribe to Pharma News